Teratoma of the central nervous system

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:252018D48.7
Who is this for?
Show terms as
1FDA treatments10Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Teratoma of the central nervous system (CNS teratoma) is a rare germ cell tumor that arises within the brain or spinal cord. Teratomas are composed of tissues derived from all three embryonic germ layers — ectoderm, mesoderm, and endoderm — and may contain differentiated structures such as hair, teeth, bone, cartilage, and glandular tissue. CNS teratomas are classified as mature (benign), immature (potentially malignant), or teratoma with malignant transformation. They most commonly occur in the midline structures of the brain, particularly the pineal region and the suprasellar area, though they can also arise in the posterior fossa or spinal cord. Symptoms depend on the tumor's location and size. Pineal region teratomas frequently cause obstructive hydrocephalus, leading to headaches, nausea, vomiting, and visual disturbances such as Parinaud syndrome (impaired upward gaze). Suprasellar teratomas may present with endocrine dysfunction, including diabetes insipidus, growth hormone deficiency, and precocious or delayed puberty. Other symptoms can include seizures, focal neurological deficits, and signs of increased intracranial pressure. In neonates and infants, CNS teratomas may present with macrocephaly and developmental delay. CNS teratomas occur predominantly in children and young adults, with a male predominance, particularly for pineal region tumors. Diagnosis involves neuroimaging (MRI/CT), measurement of serum and cerebrospinal fluid tumor markers (alpha-fetoprotein and beta-hCG), and histopathological examination. Treatment typically involves surgical resection, which is often curative for mature teratomas. Immature teratomas or those with malignant components may require adjuvant chemotherapy and/or radiotherapy. The prognosis for mature teratomas is generally favorable following complete surgical excision, while immature teratomas and those with malignant transformation carry a more guarded prognosis.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jul 1998

Thalomid: FDA approved

Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences.

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Thalomid

Thalidomide· Celgene Corporation■ Boxed WarningOrphan Drug
Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL r

Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences.

No actively recruiting trials found for Teratoma of the central nervous system at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Teratoma of the central nervous system community →

Specialists

10 foundView all specialists →
DH
Douglas S Hawkins
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 2 active trials17 Teratoma of the central nervous system publications
JG
Julia Glade-Bender
Specialist
PI on 3 active trials
TM
Tri A. Dinh, MD
Specialist
PI on 1 active trial
RM
Roger J. Packer, MD
WASHINGTON, DC
Specialist
PI on 5 active trials
LG
Lia Gore
NEWPORT, NC
Specialist
PI on 1 active trial
TH
Trent Hummel
CINCINNATI, OH
Specialist
PI on 1 active trial28 Teratoma of the central nervous system publications
PM
Patrick A. Thompson, MD
Specialist
PI on 2 active trials
SD
Steven DuBois
DERRY, NH
Specialist
PI on 1 active trial9 Teratoma of the central nervous system publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Thalomid(Thalidomide)Celgene Corporation

Travel Grants

No travel grants are currently matched to Teratoma of the central nervous system.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Teratoma of the central nervous systemForum →

No community posts yet. Be the first to share your experience with Teratoma of the central nervous system.

Start the conversation →

Latest news about Teratoma of the central nervous system

No recent news articles for Teratoma of the central nervous system.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Teratoma of the central nervous system

What is Teratoma of the central nervous system?

Teratoma of the central nervous system (CNS teratoma) is a rare germ cell tumor that arises within the brain or spinal cord. Teratomas are composed of tissues derived from all three embryonic germ layers — ectoderm, mesoderm, and endoderm — and may contain differentiated structures such as hair, teeth, bone, cartilage, and glandular tissue. CNS teratomas are classified as mature (benign), immature (potentially malignant), or teratoma with malignant transformation. They most commonly occur in the midline structures of the brain, particularly the pineal region and the suprasellar area, though th

How is Teratoma of the central nervous system inherited?

Teratoma of the central nervous system follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Teratoma of the central nervous system?

10 specialists and care centers treating Teratoma of the central nervous system are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.